Molecular Breast Imaging


Purpose

Automation to reduce the dose and acquisition time for Molecular Breast Imaging ( MBI) scans

Tag(s)


Panel

Breast Imaging

Define-AI

19060009

Originator

External use case submitter- Middlesex Hospital

Lead

Breast Panel

Panel Chair

Beth Burnside

Panel Reviewers

Breast Panel

License

Creative Commons 4.0

Status

Public Comment

Clinical Implementation


Value Proposition

MBI scans detect more cancers than mammography in dense breasts. However, lowering the dose and acquisition time is critical for wider acceptance in the medical community.

Narrative(s)

Patient presents for a routine scan. Patient given a low dose MBI, with AI enhancement. The AI works to enhance the resolution of the image despite the lower dose and acquisition time than a traditional MBI. This allows the radiologist a more effective view about findings in the breast.

Workflow Description

Imaging is performed using low-dose, reduced acquisition time MBI. AI engine operates in the background to improve the quality of the image to that comparable of a traditional MBI.

Considerations for Dataset Development


Pathologies: ductal carcinoma, lobular cardinoma, mixed carcinoma, mucinous carcinoma, papillary carcinoma, metaplastic carcinoma, tubular carcinoma, medullary carcinoma, Paget’s disease, micropapillary carcinoma, apocrine carcinoma, neuroendocrine carcinoma, secretory carcinoma, adenoid cystic carcinoma, cribriform carcinoma, sarcoma, other

tumor size: varied

Axillary lymph node involvement: absent, present

Pain: absent, present

BMI: varied

Age: over 40 years

Breast anatomy: no exclusion criteria

Technical Specifications


Inputs

DICOM study

Procedure

Low-dose Molecular Breast Imaging scans

Views

All

Data Type

DICOM

Modality

MBI

Body Region

Chest

Anatomic Focus

Breast

Pharmaceutical


Scenario




Primary Outputs

High resolution MBI image

RadElement ID


Definition

resolve the image of a low-dose MBI image

Data Type

Pixel

Value Set


Units